Viral kinetics, shedding profile, and transmission of serotype 1 Marek's disease vaccine Rispens/CVI988 in maternal antibody-free chickens

Avian Diseases

Volumn 57, Issue 2 SUPPL. 1, 2013, Pages 454-463

  Islam, Tanzila ^a   Renz, Katrin G ^a   Walkden Brown, Stephen W ^a   Ralapanawe, Sithara ^a  

^a UNIVERSITY OF NEW ENGLAND   (Australia)

Author keywords

Marek's disease virus; Quantitative real time PCR; Rispens (CVI988); Shedding; Transmission

Indexed keywords

LIVE VACCINE; MAREK DISEASE VACCINE; VIRUS ANTIBODY; VIRUS PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIRD DISEASE; CHICKEN; CLINICAL TRIAL; DISEASE TRANSMISSION; DUST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEATHER; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; KINETICS; LYMPHOCYTE; MARDIVIRUS; MAREK DISEASE; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; TIME; VIROLOGY; VIRUS REPLICATION; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; DUST; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEATHERS; HERPESVIRUS 2, GALLID; KINETICS; LYMPHOCYTES; MAREK DISEASE; MAREK DISEASE VACCINES; POULTRY DISEASES; REAL-TIME POLYMERASE CHAIN REACTION; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; TIME FACTORS; VACCINES, ATTENUATED; VIRAL PROTEINS; VIRUS REPLICATION; VIRUS SHEDDING;

GALLID HERPESVIRUS 2; GALLUS GALLUS;

EID: 84879293526     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/10341-083112-Reg.1     Document Type: Article

References (31)

1. Baigent, S., L. Smith, R. Currie, and V. Nair. Replication kinetics of Marek's disease vaccine virus in feathers and lymphoid tissues using PCR and virus isolation. J. Gen. Virol. 86:2989-2998. 2005.
2. Baigent, S. J., L. P. Smith, R. J. W. Currie, and V. K. Nair. Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model. Avian Pathol. 36:467-474. 2007.
3. Baigent, S. J., L. P. Smith, V. K. Nair, and R. J. W. Currie. Vaccinal control of Marek's disease: Current challenges, and future strategies to maximize protection. Vet. Immunol. Immunopathol. 112:78-86. 2006.
4. Boer, G. F. d., J. E. Groenendal, H. M. Boerrigter, G. L. Kok, and J. M. A. Pol. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone c against challenge infection with three very virulent MDV strains. Avian Dis. 30:276-283. 1986.
5. Burgoyne, G. H., and R. L. Witter. Effect of passively transfered immunoglobulins on Marek's disease. Avian Dis. 17:824-837. 1973.
6. Calnek, B. W. Effects of passive antibody on early pathogenesis of Marek's disease. Infect. Immun. 6:193-198. 1972.
7. Chubb, R. C., and A. E. Churchill. Effect of maternal antibody on Marek's disease. Vet. Rec. 85:303-305. 1969.
8. Churchill, A. E., L. N. Payne, and R. C. Chubb. Immunization against Marek's disease using a live attenuated virus. Nature 221:744-747. 1969
9. Fedde, M. R., G. E. Weigle, and J. R. Wideman. Influence of feed deprivation on ventilation and gas exchange in broilers: Relationship to pulmonary hypertension syndrome. Poult. Sci. 77:1704-1710. 1998.
10. Gandon, S., M. J. Mackinnon, S. Nee, and A. F. Read. Imperfect vaccines and the evolution of pathogen virulence. Nature 414:751-755. 2001
11. Haq, K., T. Fear, A. Ibraheem, M. F. Abdul-Careem, and S. Sharif. Influence of vaccination with CVI988/Rispens on load and replication of a very virulent Marek's disease virus strain in feathers of chickens. Avian Pathol. 41:69-75. 2012.
12. Islam, A., B. F. Cheetham, T. J. Mahony, P. L. Young, and S. W. Walkden-Brown. Absolute quantification of Marek's disease virus and herpesvirus of turkeys in PBL, feather tip and dust samples using real-time PCR. J. Virol. Methods 132:127-134. 2006.
13. Islam, A., and S. W. Walkden-Brown. Quantitative profiling of the shedding rate of the three Marek's disease virus (MDV) serotypes reveals that challenge with virulent MDV markedly increases shedding of vaccinal viruses. J. Gen. Virol. 88:2121-2128. 2007.
14. Islam, A., S. W. Walkden-Brown, P. J. Groves, and G. J. Underwood. Kinetics of Marek's disease virus (MDV) infection in broiler chickens 1: Effect of varying vaccination to challenge interval on vaccinal protection and load of MDV and herpesvirus of turkey in the spleen and feather dander over time. Avian Pathol. 37:225-235. 2008.
15. Islam, A. F. M. F., S. W. Walkden-Brown, P. J. Groves, and G. J. Underwood. Kinetics of Marek's disease virus (MDV) infection in broiler chickens 1: Effect of varying vaccination to challenge interval on vaccinal protection and load of MDV and herpesvirus of turkey in the spleen and feather dander over time. Avian Pathol. 37:225-235. 2008.
16. Jackson, C. A. W. Failure of imported genetic strains of layer chickens to respond to Australian-derived Marek's disease vaccines. Curr. Res. Marek's Dis. 5:448-454. 1996.
17. Okazaki, W., H. G. Purchase, and B. R. Burmester. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis. 14:413-429. 1970.
18. Osterrieder, K., and J-F. Vautherot. The genome content of Marek's disease-like viruses. In: Marek's disease: An evolving problem. F. Davison, and V. Nair, eds. Elsevier, Amsterdam, the Netherlands. pp. 17-31. 2004.
19. Purchase, H. G. Control of Mareks disease by vaccination. Worlds Poult. Sci. J. 29:238-250. 1973.
20. Renz, K. In vitro and in vivo characterization of selected Australian isolates of Marek's disease virus. Ph. D. Dissertation. University of New England, Armidale, Australia. p. 256. 2008.
21. Renz, K. G., B. F. Cheetham, and S. W. Walkden-Brown. Differentiation between pathogenic serotype 1 isolates of Marek's disease virus and the Rispens CVI988 vaccine in australia using real-time PCR and high resolution melt curve analysis. J. Virol. Methods 187:144-152. 2013.
22. Renz, K. G., A. Islam, B. E. Cheetham, and S. W. Walkden-Brown. Absolute quantification using real-time polymerase chain reaction of Marek's disease virus serotype 2 in field dust samples, feather tips and spleens. J. Virol. Methods 135:186-191. 2006.
23. Rispens, B. H., H. van Vloten, N. Mastenbroek, H. J. Maas, and K. A. Schat. Control of Marek's disease in the Tetherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis. 16:108-125. 1972.
24. Rispens, B. H., H. van Vloten, N. Mastenbroek, J. L. Maas, and K. A. Schat. Control of Marek's disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus. Avian Dis. 16:126-138. 1972.
25. Sharma, J. M., and C. K. Graham. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell free Marek's disease vaccine. Avian Dis. 26:860-870. 1982.
26. van Iddekinge, B., L. Stenzler, K. A. Schat, H. Boerrigter, and G. Koch. Genome analysis of Marek's disease virus strain CVI-988: Effect of cell culture passage on the inverted repeat regions. Avian Dis. 43:182-188. 1999
27. Witter, R. L. Evolution of virulence of Marek's disease virus: Evidence for a novel pathotype. Curr. Res. Marek's Dis. 5:86-91. 1996.
28. Witter, R. L. Increased virulence of Marek's disease virus field isolates. Avian Dis. 41:149-163. 1997.
29. Witter, R. L., L. F. Lee, and A. M. Fadly. Characteristics of CVI988/Rispens and r2/23, two prototype vaccine strains of serotype 1 Marek's disease virus. Avian Dis. 39:269-284. 1995.
30. Witter, R. L., R. F. Silva, and L. F. Lee. New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: Selected biological and molecular characteristics. Avian Dis. 31:829-840. 1987.
31. Zelnik, V., O. Harlin, F. Fehler, B. Kaspers, T. W. Gobel, V. K. Nair, and N. Osterrieder. An enzyme-linked immunosorbent assay (ELISA) for detection of Marek's disease virus-specific antibodies and its application in an experimental vaccine trial. J. Vet. Med. B 51:61-67. 2004.